LATEST NEWS

Nestle Label Push Tests India’s Public Health Priorities

Nestle’s Call Puts Food Labels Under Fresh Scrutiny

Nestle’s demand for consultation on India’s proposed front-of-pack food labelling has reopened a contentious public-health debate: should food companies whose sales could be affected by warning labels have a significant role in designing those warnings? Nestle argues that industry consultation can help produce scientifically sound and workable regulations. Activists counter that industry influence has already contributed to delays in creating simple warnings for products high in sugar, salt and saturated fat.

India’s Long-Running Labelling Debate

India requires packaged foods to provide nutritional information, but consumers still do not have mandatory, prominent front-of-pack warnings such as “High in Sugar” or “High in Salt”. The Food Safety and Standards Authority of India (FSSAI) has spent years considering such a system amid increasing concerns over ultra-processed foods and diet-related health risks.

The government had considered colour-coded warning labels highlighting high levels of sugar, salt and fat. However, Reuters reported that FSSAI dropped that approach after opposition from companies including Coca-Cola and food-industry associations at a March meeting. Instead, the regulator moved towards a black-and-white nutrition table, which critics argue requires consumers to interpret complicated numerical information themselves.

In an August affidavit before the Supreme Court, FSSAI proposed displaying added sugar, saturated fat and salt per 100 grams, together with serving-size information and recommended daily intake figures based on the ICMR’s 2024 dietary guidelines. The suggested daily limits are 25 grams of added sugar, 10 grams of saturated fat and 5 grams of salt. Mandatory warning symbols, however, were not proposed.

The Supreme Court has increased the pressure for a decision, giving the government two weeks on August 13 to place its final position on record and warning that it could issue directions if the regulator failed to act.

Nestle Says Industry Can Be Consulted, Activists Say No

Nestle CEO Philipp Navratil has said the company supports front-of-pack labelling for products high in sugar, salt and fat, but believes manufacturers should be consulted so that regulations are developed scientifically and enable informed consumer choices.

There is a legitimate argument for technical consultation. Food manufacturers possess detailed knowledge about ingredients, serving sizes, production processes, reformulation and supply chains. Their input can help regulators avoid inconsistencies and impractical implementation requirements.

But consultation cannot become a veto. Activists point to an inherent conflict of interest: clearer warnings could influence consumers away from products that generate substantial revenues. Public-health policy therefore needs independent nutritional evidence, with industry recommendations transparently disclosed and treated as one source of information—not the final authority.

Why Front-Of-Pack Warnings Matter

The controversy reflects a broader problem: many consumers cannot quickly assess health risks from dense back-of-pack tables, technical ingredient lists or promotional claims. A simple warning can communicate information within seconds, particularly when shoppers are making rapid purchasing decisions.

The stakes are considerable in India, one of the world’s largest consumer markets, where packaged food and beverage consumption is expanding across metropolitan areas as well as smaller towns.

Consumer Clarity Must Come First

The real policy question is not whether industry should be consulted—it inevitably will be—but whose interests ultimately determine the rules. India needs a system that combines scientific rigour, regulatory transparency and meaningful consumer protection.

FSSAI can achieve that balance by publishing industry submissions, giving independent nutrition experts a central role and establishing clear thresholds and an enforceable implementation timeline. Consultation can strengthen regulation; allowing commercial interests to dilute clear warnings can defeat its purpose. The final test should therefore be simple: can an ordinary consumer understand the health risk before making the purchase?

 

(With agency inputs)